Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Thyroid Nodule 1 Obesity 1 Hypothyroidism 1 Hyperthyroidism 1 Goiter 1 Diabetes Mellitus 1 Central Nervous System Neoplasms 1

Interventions

Radiotherapy 122 Temozolomide 110 Carboplatin 53 Filgrastim 46 Vincristine 43 Etoposide 39 Cyclophosphamide 37 Chemotherapy, Adjuvant 37 Cisplatin 36 Carmustine 32 Irinotecan 27 Peripheral Blood Stem Cell Transplantation 25 Magnetic Resonance Spectroscopy 24 Lomustine 22 Thiotepa 21 Methotrexate 20 Granulocyte Colony-Stimulating Factor 18 Procarbazine 16 Bevacizumab 16 Surgical Procedures, Operative 15 O(6)-benzylguanine 14 etoposide phosphate 13 Drug Therapy 13 Topotecan 12 Paclitaxel 12 Ifosfamide 12 Thalidomide 11 Radiation 11 sargramostim 10 Specimen Handling 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Central Nervous System Neoplasms × Remote Consultation × Clear all

NCT06485310 2026-01-20

TECAP

Centre Hospitalier Universitaire de la Réunion

Phase NA Not yet recruiting

Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡